Literature DB >> 15356402

It might be wise to consider adding androgen to the estrogen or estrogen-progestin regimens in the appropriate patients.

Morrie M Gelfand.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15356402     DOI： 10.1097/01.gme.0000135245.27220.66

Source DB:  PubMed          Journal:  Menopause        ISSN： 1072-3714            Impact factor:   2.953


× No keyword cloud information.
  1 in total

1.  Low salivary testosterone levels in patients with breast cancer.

Authors:  Constantine Dimitrakakis; David Zava; Spyros Marinopoulos; Alexandra Tsigginou; Aris Antsaklis; Rebecca Glaser
Journal:  BMC Cancer       Date:  2010-10-11       Impact factor: 4.430
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.